Cargando…
Glycogen Synthase Kinase-3β Is Associated with the Prognosis of Hepatocellular Carcinoma and May Mediate the Influence of Type 2 Diabetes Mellitus on Hepatocellular Carcinoma
BACKGROUND: Although many studies have shown glycogen synthase kinase-3β(GSK-3β) was associated with type 2 diabetes mellitus(T2DM) and implicated with a wide range of cancers, the role of GSK-3β in hepatocellular carcinoma(HCC) and the correlation among GSK-3β, T2DM and HCC remains unclear. Our obj...
Autores principales: | Qiao, Guoliang, Le, Yuan, Li, Jun, Wang, Lianghuan, Shen, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144855/ https://www.ncbi.nlm.nih.gov/pubmed/25157753 http://dx.doi.org/10.1371/journal.pone.0105624 |
Ejemplares similares
-
Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIP(L) in hepatocellular carcinoma
por: Zhang, Na, et al.
Publicado: (2018) -
AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway
por: Wang, Miao, et al.
Publicado: (2018) -
The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker
por: Chen, Shuo, et al.
Publicado: (2016) -
Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020) -
The Transcriptional Profiling of Glycogenes Associated with Hepatocellular Carcinoma Metastasis
por: Liu, Tianhua, et al.
Publicado: (2014)